USRD:NASDAQThemes US R&D Champions ETF Analysis

USRD is trading at $37.53, just above its immediate support of $36.11 and well below the 52‑week high of $40.38. The fund’s 20‑day SMA ($37.94) sits above the 50‑day ($35.73) and 200‑day ($33.86) averages, indicating a positive longer‑term momentum. However, the MACD histogram is negative (‑0.33) and the MACD line sits below its signal, signalling short‑term bearish pressure. RSI at 51.6 suggests the ETF is neither overbought nor oversold, reinforcing a neutral short‑term stance. Volume has been rising, with today’s 1,609 shares traded versus a 10‑day average of 270, supporting the bullish trend direction. The fund’s expense ratio of 0.29% is modest for a thematic ETF and tracking error is essentially zero.
The ETF’s beta of 1.26 and 30‑day volatility of 24.4% point to higher sensitivity to market swings, which amplifies both upside and downside risk. A YTD return of +17.94% coupled with an Extreme Greed sentiment (Fear‑Greed Index 89.9) reflects strong recent investor enthusiasm. Nonetheless, total assets of only $1.18 million and modest average daily volumes raise liquidity concerns, especially for larger trades. Concentration in U.S. R&D‑intensive companies adds sector‑specific risk, though the fund’s Large‑Blend classification offers some diversification. The dividend yield is low at 0.36%, indicating that total return is driven primarily by capital appreciation. Overall, the ETF sits at a crossroads where bullish fundamentals meet heightened volatility and liquidity constraints.